We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TITC:ATHEXTitan S.A. Analysis

Data as of 2026-06-21 - not real-time

€53.55

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Titan S.A. is trading at €53.55, comfortably above its 20‑day (≈€50.5) and 50‑day (≈€48.8) simple moving averages. The 200‑day SMA sits near €46.4, indicating a long‑term upward bias. Momentum indicators are supportive, with an RSI of 64 and a bullish MACD crossover (line above signal). The recent price action has respected a clear support zone around €47.8 while testing resistance near €54.5. Volume has been on an increasing trend, reinforcing the price strength. The Fear & Greed index reads “Extreme Greed,” suggesting strong market appetite for risk‑on assets like TITC.
On the valuation side, a trailing P/E of 17 and a price‑to‑book of 1.95 place the stock near fair value relative to peers. The company delivers a solid 2.05% dividend yield with a payout ratio below 35%, supporting sustainability. Debt‑to‑equity stands at about 51%, manageable given the €445 M cash buffer and steady operating margins. Revenue growth is flat (‑0.4%) but margins remain healthy (gross ~28%, operating ~14%). Analyst consensus targets a mean price of €70, implying roughly 30% upside. Geographic diversification across Europe, the Middle East, the U.S., and Brazil mitigates single‑market exposure but adds currency considerations.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above key moving averages
  • Bullish MACD and strong RSI
  • Increasing volume confirming momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Upside potential toward €70 target
  • Sustainable dividend yield
  • Fair valuation with solid cash position

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Cyclical nature of building‑materials sector
  • Moderate debt level relative to cash
  • Geographic diversification and currency exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-0.40%
Profit Margin9.62%
P/E Ratio17.0
ROE12.82%
ROA7.23%
Debt/Equity51.46
P/B Ratio2.0

Technical Analysis

TrendBullish
RSI64.4
Support€47.80
Resistance€54.50
MA 20€50.53
MA 50€48.80
MA 200€46.44
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Target Price€70.00
Upside/Downside30.72%
GradeFair
TypeValue
Dividend Yield2.05%

Risk Assessment

Beta0.50
Volatility35.90%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.